"The findings, published in Science, suggest the virus is mutating quickly and in ways that could affect current diagnostics and future vaccines and treatments, such as GlaxoSmithKline's Ebola vaccine, which was just fast-tracked to begin clinical trials, or the antibody drug ZMapp, being developed by California biotech Mapp Biopharmaceutical."
Article on http://ow.ly/B8wHH:
CHICAGO, Aug 28 (Reuters) – Genetic studies of some of the
earliest Ebola cases in Sierra Leone reveal more than 300
genetic changes in the virus as it leapt from person to person,
changes that could blunt